Selexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.
Lauren J. VanHook, PharmD
Advertisement
Lauren J. VanHook is a PGY-1 pharmacy resident at John Dempsey Hospital/UConn Health, Farmington, Conn.
Articles by Lauren J. VanHook, PharmD
Advertisement
Latest Updated Articles
- FDA approves PAH treatment
May 10th 2016
Advertisement
Advertisement
Trending on Drug Topics
1
ACIP's Vacancy Leaves Pharmacists Navigating COVID-19 Confusion
2
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
3
Study Links Live Flu Vaccine With Rise in Pneumococcal Disease
4
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
5